DK1204662T3 - Azaindoler med serotoninreceptoraffinitet - Google Patents
Azaindoler med serotoninreceptoraffinitetInfo
- Publication number
- DK1204662T3 DK1204662T3 DK00949846T DK00949846T DK1204662T3 DK 1204662 T3 DK1204662 T3 DK 1204662T3 DK 00949846 T DK00949846 T DK 00949846T DK 00949846 T DK00949846 T DK 00949846T DK 1204662 T3 DK1204662 T3 DK 1204662T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- formula
- azaindoles
- double bond
- serotonin receptor
- Prior art date
Links
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 title 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 title 1
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 title 1
- 108091005435 5-HT6 receptors Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14834399P | 1999-08-12 | 1999-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1204662T3 true DK1204662T3 (da) | 2004-10-04 |
Family
ID=22525363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00949846T DK1204662T3 (da) | 1999-08-12 | 2000-08-14 | Azaindoler med serotoninreceptoraffinitet |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1204662B1 (enExample) |
| JP (1) | JP4969004B2 (enExample) |
| AT (1) | ATE268330T1 (enExample) |
| AU (1) | AU779832B2 (enExample) |
| CA (1) | CA2382247C (enExample) |
| DE (1) | DE60011269T2 (enExample) |
| DK (1) | DK1204662T3 (enExample) |
| ES (1) | ES2222219T3 (enExample) |
| MX (1) | MXPA02001473A (enExample) |
| WO (1) | WO2001012629A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10030037A1 (de) | 2000-06-17 | 2001-12-20 | Mann & Hummel Filter | Zylindrische Filterpatrone mit Stützrohr |
| ITRM20010356A1 (it) * | 2001-06-21 | 2002-12-23 | Sigma Tau Ind Farmaceuti | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. |
| HUP0402640A3 (en) * | 2001-12-20 | 2012-09-28 | Wyeth Corp | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands, process for their preparation and pharmaceutical compositions thereof |
| TW200301251A (en) * | 2001-12-20 | 2003-07-01 | Wyeth Corp | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| GB0202679D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Group Ltd | Novel compounds |
| ATE346068T1 (de) * | 2002-03-27 | 2006-12-15 | Glaxo Group Ltd | Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden |
| UA78999C2 (en) * | 2002-06-04 | 2007-05-10 | Wyeth Corp | 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6 |
| EP1897876A3 (en) | 2002-06-20 | 2009-03-18 | Biovitrum AB (publ) | Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| TW200403243A (en) | 2002-07-18 | 2004-03-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| EP1592772A2 (en) * | 2003-01-31 | 2005-11-09 | Pfizer Products Incorporated | 5ht7 antagonists and inverse agonists |
| CN100482662C (zh) * | 2003-02-14 | 2009-04-29 | 惠氏公司 | 作为5-羟基色胺-6配体的杂环基-3-磺酰基氮杂吲哚或-氮杂吲唑衍生物 |
| JP2006528186A (ja) * | 2003-07-23 | 2006-12-14 | ワイス | 5−ヒドロキシトリプタミン−6リガンドとしてのスルホニルジヒドロベンゾイミダゾロン化合物 |
| ES2222828B1 (es) * | 2003-07-30 | 2006-04-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 1-sulfonilindoles, su preparacion y su aplicacion como medicamentos. |
| AU2007217040A1 (en) * | 2006-02-17 | 2007-08-30 | Memory Pharmaceuticals Corporation | Compounds having 5-HT6 receptor affinity |
| EP2046741B1 (en) * | 2006-07-03 | 2012-10-31 | Proximagen Ltd. | Indoles as 5-ht6 modulators |
| WO2012160464A1 (en) * | 2011-05-26 | 2012-11-29 | Daiichi Sankyo Company, Limited | Heterocyclic compounds as protein kinase inhibitors |
| EP3083588B1 (en) | 2013-12-20 | 2020-12-09 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| EP3166924B1 (en) | 2014-07-08 | 2019-02-20 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9406128A (pt) * | 1993-03-01 | 1996-02-27 | Merck Sharp & Dohme | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| EP0875513A1 (en) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituted heteroaromatic 5-HT 1F agonists |
| US5905084A (en) * | 1997-11-14 | 1999-05-18 | Eli Lilly And Company | 5-HTIF -agonists effective in treating migraine |
| US6562809B1 (en) * | 1998-09-18 | 2003-05-13 | Nps Allelix Corp. | 3-bicycloindole compounds |
-
2000
- 2000-08-14 MX MXPA02001473A patent/MXPA02001473A/es active IP Right Grant
- 2000-08-14 AT AT00949846T patent/ATE268330T1/de active
- 2000-08-14 ES ES00949846T patent/ES2222219T3/es not_active Expired - Lifetime
- 2000-08-14 WO PCT/IB2000/001122 patent/WO2001012629A1/en not_active Ceased
- 2000-08-14 EP EP00949846A patent/EP1204662B1/en not_active Expired - Lifetime
- 2000-08-14 AU AU63103/00A patent/AU779832B2/en not_active Ceased
- 2000-08-14 DK DK00949846T patent/DK1204662T3/da active
- 2000-08-14 DE DE60011269T patent/DE60011269T2/de not_active Expired - Lifetime
- 2000-08-14 JP JP2001517527A patent/JP4969004B2/ja not_active Expired - Fee Related
- 2000-08-14 CA CA2382247A patent/CA2382247C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4969004B2 (ja) | 2012-07-04 |
| JP2003507380A (ja) | 2003-02-25 |
| DE60011269T2 (de) | 2005-06-23 |
| ES2222219T3 (es) | 2005-02-01 |
| WO2001012629A1 (en) | 2001-02-22 |
| DE60011269D1 (de) | 2004-07-08 |
| CA2382247A1 (en) | 2001-02-22 |
| EP1204662B1 (en) | 2004-06-02 |
| AU6310300A (en) | 2001-03-13 |
| CA2382247C (en) | 2010-09-28 |
| MXPA02001473A (es) | 2003-07-21 |
| EP1204662A1 (en) | 2002-05-15 |
| AU779832B2 (en) | 2005-02-10 |
| ATE268330T1 (de) | 2004-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1204662T3 (da) | Azaindoler med serotoninreceptoraffinitet | |
| IL110091A (en) | POLYSUBSTITUTED IMIDAZO £4, 5-c| PYRIDIN-4-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| BR0315405A (pt) | Compostos inibidores da integrase tricìclica pré-organizados | |
| AR057023A1 (es) | Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa | |
| CO5721006A2 (es) | Derivados de pirazolo-quinazolina, proceso para su preparacion y su uso como inhibidores de quinasa | |
| CO4700455A1 (es) | Derivados tetraciclicos y proceso para su preparacion | |
| ATE227719T1 (de) | Heteroaryl-zyklische acetale | |
| BR9914370A (pt) | Derivados de tetraidrobenzazepina úteis comomoduladores de receptores para a dopamina d3(agentes antipsicóticos) | |
| ATE94061T1 (de) | Arylsubstituierte aminderivate verwendbar in der krebstherapie. | |
| DK0733621T3 (da) | Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse | |
| EA200000400A1 (ru) | Галогензамещенные тетрациклические производные тетрагидрофурана | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| MX9205207A (es) | Derivados de dihidropiridina, procedimiento para su preparacion y composicion farmaceutica que los comprende | |
| CA2316388A1 (en) | Tetrahydrobenzindole derivative | |
| FI884088A0 (fi) | Foerfarande foer framstaellning av 17-substituerade androsta-1,4-dien-3-onderivat. | |
| EP0712398A1 (en) | BENZOPYRANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR027454A1 (es) | Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos | |
| MXPA04001171A (es) | Compuestos policiclicos condensados. | |
| DK1163258T3 (da) | Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis | |
| NO955071D0 (no) | abeo-Ergolin-derivater som 5HT1A-ligander | |
| DK0582506T3 (da) | Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse af disse | |
| DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| DK602383A (da) | 1,1-diphenylpropanolderivater | |
| GB0114699D0 (en) | Organic compounds | |
| MY142362A (en) | Pharmaceutical composition for promoting angiogenesis |